FT Options’s Medicines Co MDCO Stock Holding History

FT Options’s Portfolio MDCO Stock Details MDCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-16,931	Closed	-$644K	–	287
2017 Q2	$644K	Sell	16,931 -7,168	-30%	-$319K	1.11%	24
2017 Q1	$1.18M	Buy	+24,099	New	+$1.1M	1.55%	15

Other funds holding MDCO

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Aviva Holdings New Providence, Bahamas $20.5M AUM 117.01% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bridger Management New York $128M AUM 9.54% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FT Options's MDCO Position: Q3 2017 in Review

FT Options sold out of Medicines Co (MDCO) in Q3 2017, closing a stake of 16,931 shares — an estimated $644K sold.

FT Options first reported a position in MDCO in Q1 2017 and held it in 2 quarters. The position peaked at $1.18M in Q1 2017. 190 funds tracked by Wall St. Rank hold MDCO as of Q3 2017.

FT Options reported no remaining Medicines Co position as of Q3 2017 after selling out during the quarter.
FT Options sold 16,931 Medicines Co shares in Q3 2017, an estimated $644K.
FT Options first reported a position in Medicines Co in Q1 2017 and held it in 2 quarters.
FT Options's Medicines Co position peaked at $1.18M in Q1 2017.
190 funds tracked by Wall St. Rank held Medicines Co as of Q3 2017.

Based on FT Options's 13F filing for Q3 2017, filed 13 Nov 2017.